Diffusely Abnormal White Matter in Progressive Multiple Sclerosis: In Vivo Quantitative MR Imaging Characterization and Comparison between Disease Types

od Vrenken, H., Seewann, A., Knol, D.L., Polman, C.H., Barkhof, F., Geurts, J.J.G.
izdano v AJNR Am J Neuroradiol (2010)

Normal-Appearing White Matter Changes Vary with Distance to Lesions in Multiple Sclerosis

od Vrenken, H., Geurts, J.J.G., Knol, D.L., Polman, C.H., Castelijns, J.A., Pouwels, P.J.W., Barkhof, F.
izdano v AJNR Am J Neuroradiol (2006)

Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study()

od Van der Meer, M.L., Tewarie, P., Schoonheim, M.M., Douw, L., Barkhof, F., Polman, C.H., Stam, C.J., Hillebrand, A.
Izdano 2013

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis

od Freedman, MS, Metzig, C, Kappos, L, Polman, CH, Edan, G, Hartung, H-P, Miller, DH, Montalban, X, Yarden, J, Spector, L, Fire, E, Dotan, N, Schwenke, S, Lanius, V, Sandbrink, R, Pohl, C
Izdano 2012

White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

od Wiebenga, O.T., Schoonheim, M.M., Hulst, H.E., Nagtegaal, G.J.A., Strijbis, E.M.M., Steenwijk, M.D., Polman, C.H., Pouwels, P.J.W., Barkhof, F., Geurts, J.J.G.
izdano v AJNR Am J Neuroradiol (2016)

Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

od Wiebenga, O.T., Klauser, A.M., Schoonheim, M.M., Nagtegaal, G.J.A., Steenwijk, M.D., van Rossum, J.A., Polman, C.H., Barkhof, F., Pouwels, P.J.W., Geurts, J.J.G.
izdano v AJNR Am J Neuroradiol (2015)

Genetic Correlations of Brain Lesion Distribution in Multiple Sclerosis: An Exploratory Study

od Sombekke, M.H., Vellinga, M.M., Uitdehaag, B.M.J., Barkhof, F., Polman, C.H., Arteta, D., Tejedor, D., Martinez, A., Crusius, J.B.A., Peña, A.S., Geurts, J.J.G., Vrenken, H.
izdano v AJNR Am J Neuroradiol (2011)

Differential diagnosis of suspected multiple sclerosis: a consensus approach

od Miller, DH, Weinshenker, BG, Filippi, M, Banwell, BL, Cohen, JA, Freedman, MS, Galetta, SL, Hutchinson, M, Johnson, RT, Kappos, L, Kira, J, Lublin, FD, McFarland, HF, Montalban, X, Panitch, H, Richert, JR, Reingold, SC, Polman, CH
Izdano 2008

Multicontrast MR Imaging at 7T in Multiple Sclerosis: Highest Lesion Detection in Cortical Gray Matter with 3D-FLAIR

od Kilsdonk, I.D., de Graaf, W.L., Soriano, A. Lopez, Zwanenburg, J.J., Visser, F., Kuijer, J.P.A., Geurts, J.J.G., Pouwels, P.J.W., Polman, C.H., Castelijns, J.A., Luijten, P.R., Barkhof, F., Wattjes, M.P.
izdano v AJNR Am J Neuroradiol (2013)

Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration

od Kearney, H, Rocca, MA, Valsasina, P, Balk, L, Sastre-Garriga, J, Reinhardt, J, Ruggieri, S, Rovira, A, Stippich, C, Kappos, L, Sprenger, T, Tortorella, P, Rovaris, M, Gasperini, C, Montalban, X, Geurts, JJG, Polman, CH, Barkhof, F, Filippi, M, Altmann, DR, Ciccarelli, O, Miller, DH, Chard, DT
Izdano 2014